← Back to Search

Genetics ADvISER Decision Aid for Cancer

N/A

Waitlist Available

Led By Yvonne Bombard, PhD

Research Sponsored by Unity Health Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed at immediately after baseline/ post intervention, 2 months and 4 months.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests Genetics ADvISER, a digital tool that helps adult cancer patients understand and choose which genetic test results they want to receive. It aims to reduce confusion and anxiety by providing clear information and support.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed at immediately after baseline/ post intervention, 2 months and 4 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed at immediately after baseline/ post intervention, 2 months and 4 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at immediately after baseline/ post intervention, 2 months and 4 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Decisional Conflict Scale (DCS)

Secondary study objectives

Acceptability

Hospital Anxiety and Depression Scale (HADS)

Knowledge

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Genetics ADviSER Decision Aid Plus Standard Genetic CounsellingExperimental Treatment1 Intervention

Participants in the intervention arm will use the Genetics ADviSER to learn about genomic sequencing and to select which results they would like to receive from genomics sequencing results. After using the Genetics ADviSER decision aid they will speak with genetic counselor to discuss their choices and to finalized their selection.

Group II: Standard Genetic Counselling OnlyActive Control1 Intervention

Participants will speak with a genetic counsellor over the phone to learn about genomic sequencing and select which incidental findings they would like to receive from genomic sequencing.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Genetics ADvISER Decision Aid Plus Standard Genetic Counselling

2021

N/A

~140

Do I qualify?Apply below to find out